Syndax Pharmaceuticals Inc (SNDX) — Net Asset Quality Index
Syndax Pharmaceuticals Inc (SNDX) has a Net Asset Quality Index of 8.8% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $472.67 Million minus total liabilities of $431.05 Million yields net assets of $41.62 Million. A higher index indicates a stronger, lower-leverage balance sheet. See SNDX days of operational coverage to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Syndax Pharmaceuticals Inc Net Asset Quality Index Over Time (2011–2025)
This chart shows how Syndax Pharmaceuticals Inc's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the index stands at 8.8%, representing net assets of $41.62 Million against total assets of $472.67 Million USD. Explore cash flow conversion of Syndax Pharmaceuticals Inc to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Syndax Pharmaceuticals Inc (2011–2025)
The table below presents the year-by-year Net Asset Quality Index for Syndax Pharmaceuticals Inc from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of Syndax Pharmaceuticals Inc.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 12.2% | $64.63 Million | $529.71 Million | $465.08 Million | ▼ -27.6 pp |
| 2024 | 39.8% | $288.12 Million | $724.82 Million | $436.69 Million | ▼ -50.7 pp |
| 2023 | 90.4% | $554.20 Million | $612.88 Million | $58.68 Million | ▼ -3.6 pp |
| 2022 | 94.0% | $467.45 Million | $497.24 Million | $29.79 Million | ▲ +3.2 pp |
| 2021 | 90.8% | $408.37 Million | $449.66 Million | $41.29 Million | ▲ +6.9 pp |
| 2020 | 83.9% | $252.19 Million | $300.61 Million | $48.42 Million | ▲ +34.1 pp |
| 2019 | 49.7% | $31.60 Million | $63.52 Million | $31.93 Million | ▼ -13.5 pp |
| 2018 | 63.2% | $53.05 Million | $83.94 Million | $30.89 Million | ▼ -12.8 pp |
| 2017 | 76.0% | $104.32 Million | $137.19 Million | $32.87 Million | ▼ -1.1 pp |
| 2016 | 77.2% | $84.14 Million | $109.01 Million | $24.87 Million | ▲ +3.0 pp |
| 2015 | 74.2% | $66.70 Million | $89.90 Million | $23.20 Million | ▲ +118.8 pp |
| 2014 | -44.6% | $-5.72 Million | $12.82 Million | $18.53 Million | ▼ -114.1 pp |
| 2013 | 69.5% | $11.85 Million | $17.06 Million | $5.21 Million | ▲ +2009.1 pp |
| 2012 | -1939.6% | $-29.29 Million | $1.51 Million | $30.80 Million | ▼ -1541.5 pp |
| 2011 | -398.1% | $-19.05 Million | $4.79 Million | $23.84 Million | — |